[HTML][HTML] Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care
AL Frank, M Kreuter, L Schwarzkopf - Respiratory Medicine, 2019 - Elsevier
Introduction Evidence about the economic burden related to interstitial lung diseases (ILDs)
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …
Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
AL Frank, M Kreuter, L Schwarzkopf - Respiratory Medicine, 2019 - europepmc.org
Methods Using claims data of individuals diagnosed with Idiopathic Interstitial Pneumonia
(IIP)(n= 14 453) or sarcoidosis (n= 9106) between 2010 and 2013, we calculated total and …
(IIP)(n= 14 453) or sarcoidosis (n= 9106) between 2010 and 2013, we calculated total and …
Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care
AL Frank, M Kreuter… - Respiratory …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Evidence about the economic burden related to interstitial lung diseases (ILDs)
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …
[HTML][HTML] Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care
AL Frank, M Kreuter, L Schwarzkopf - Respiratory Medicine, 2019 - resmedjournal.com
Introduction Evidence about the economic burden related to interstitial lung diseases (ILDs)
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …